FOXO TechnologiesFOXOD -65.71%35 EBIT per Share is $50.15 as of Mar. 2026. GuruFocus rates FOXOD with a GF Score™ of 35/100. The stock has 5 warning signs investors should review. Among 529 Healthcare Providers & Services companies, FOXO Technologies ranks worse than 189035.73% on this metric.
FOXO Technologies's EBIT per Share for the
three
months ended in Mar. 2026 was $-0.47.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $50.15.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for FOXO Technologies's EBIT per Share or its related term are showing as below:
FOXOD's 3-Year EBIT Growth Rate is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 11.8 * Ranked among companies with meaningful 3-Year EBIT Growth Rate only.
FOXO Technologies (OTCPK:FOXOD) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
FOXO Technologies EBIT per Share Related Terms
FOXO Technologies EBIT per Share Historical Data
* Premium members only.
The historical data trend for FOXO Technologies's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $50.15
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FOXO Technologies (FOXOD) has a EBIT per Share of $50.15 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on FOXO Technologies and its competitors. According to the industry distribution chart, FOXO Technologies ranks #999999 out of 529 companies in the Healthcare Providers & Services industry.
Is FOXO Technologies' EBIT per Share too high?
FOXO Technologies' current EBIT per Share is $50.15. The Healthcare Providers & Services industry median EBIT per Share is 11.80. FOXO Technologies' value of $50.15 is 325% above this industry median. Based on the distribution chart, FOXO Technologies ranks #999999 out of 529 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, FOXO Technologies has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does FOXO Technologies' EBIT per Share compare to WORX and LGMK?
According to the Healthcare Providers & Services industry distribution chart, FOXO Technologies ranks #999999 out of 529 companies for EBIT per Share. This places FOXO Technologies in the lower half of its industry. The industry median EBIT per Share is 11.80. FOXO Technologies' value of $50.15 is 325% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Healthcare Providers & Services company?
The median EBIT per Share among Healthcare Providers & Services companies is 11.80, based on 529 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. FOXO Technologies's current EBIT per Share of $50.15 is 325% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on FOXO Technologies and its competitors. For the Healthcare Providers & Services industry, the median EBIT per Share is 11.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. FOXO Technologies's current EBIT per Share is $50.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is FOXO Technologies stock overvalued right now?
FOXO Technologies (FOXOD) has a current EBIT per Share of $50.15. The current EBIT per Share is $50.15 and 325% above the Healthcare Providers & Services industry median of 11.80. FOXO Technologies' overall GF Score™ is 35/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For FOXO Technologies (FOXOD), the current EBIT per Share is $50.15 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
FOXO Technologies Inc is a healthcare services and technology company. It currently operates four synergistic divisions: (i) a rural hospital division; (ii) a mental and behavioral health division; (iii) an information, data and biospecimen sourcing division; and (iv) an epigenetics diagnostics and interpretation division. The Company manages and classifies its business into three reportable business segments: (i) Healthcare, (ii) Life Science Services and (iii) Labs. Myrtle, RCHI and SCCH operate under the Healthcare segment and Vector operates under the Life Science Services segment. The company generates majority of its revenue from Healthcare segment. It includes RCHI's hospital, BSF, has 25 inpatient beds, and a 24/7 emergency department and provides ancillary services.
35GF Score
Get the complete analysis for FOXOD
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FOXOD has been successfully added to your 
